SCHEMBL7127487

SCHEMBL7127487

O=C(Nc1nc2ccc(Cl)cc2s1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 1/20 0.74
DYRK1A Q13627 2/20 0.63
FSCN1 Q16658 2/20 0.61
MAPT P10636 5/20 0.61
NPC1 O15118 4/20 0.61
RAB9A P51151 4/20 0.61
CACNA1B Q00975 1/20 0.61
APBA1 Q02410 1/20 0.61
CXCR2 P25025 1/20 0.61
MCL1 Q07820 1/20 0.60
ALDH1A1 P00352 4/20 0.58
SMN1; SMN2 Q16637 4/20 0.58
LMNA P02545 3/20 0.58
RXFP1 Q9HBX9 1/20 0.57
KMT2A Q03164 4/20 0.56
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP7 Q9BQF6 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
MEN1 O00255 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7129461 0.94 DYRK1A (0.70) MMP13DYRK1AMAPTNPC1RAB9A
SCHEMBL7124297 0.90 DYRK1A (0.61) MMP13DYRK1AMAPTNPC1RAB9A
SCHEMBL7162058 0.89 DYRK1A (0.64) MMP13DYRK1AMAPTNPC1RAB9A
SCHEMBL7119606 0.89 MAPT (0.61) MMP13DYRK1AMAPTNPC1RAB9A
SCHEMBL5731624 0.88 MAPT (0.69) MMP13DYRK1AMAPTNPC1RAB9A
SCHEMBL7123602 0.88 DYRK1A (0.67) MMP13DYRK1AMAPTNPC1RAB9A
SCHEMBL7127519 0.87 SCD (0.73) MMP13DYRK1AMAPTNPC1RAB9A
SCHEMBL7125923 0.87 DYRK1A (0.57) MMP13DYRK1AMAPTNPC1RAB9A
SCHEMBL7129459 0.83 MAPT (0.55) MMP13DYRK1AMAPTNPC1RAB9A
SCHEMBL7125975 0.83 MAPT (0.62) MMP13DYRK1AMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD MMP13 2283/4885DYRK1A 3783/4885FSCN1 4572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.